Summary
Zymography of concentrated conditioned medium (CM) from protein-free NS0 myeloma cell cultures showed that this cell line produced and released/secreted several proteases. Two caseinolytic activities at 45–50 and 90 kDa were identified as aspartic acid proteases, and at least two cathepsins of the papain-like cysteine protease family with molecular masses of 30–35 kDa were found by gelatin zymography. One of these cathepsins was identified as cathepsin L by using an enzyme assay exploiting the substrate Z-Phe-Arg-AMC and the inhibitor Z-Phe-Tyr-t(Bu)-DMK. The aspartic acid and cysteine proteases were active only at acidic pH and are therefore not a potential risk for degrading the product or affecting cell growth during culture. Secreted proforms of cathepsins may, however, possess mitogenic functions, but addition of anti-procathepsin L antibodies to NS0 cultures did not influence proliferation. The recombinant antibody product was not degraded in cell-free CM incubated at pH 7, but when the pH was decreased to 3.5–4, the aspartic acid proteases degraded the product. Gelatin zymography also revealed the presence of several serine proteases in NS0 CM, one at 85 kDa and two at 50 kDa, with pH optima close to culture pH. Addition of the serine protease inhibitor aprotinin significantly increased the specific proliferation rate as compared to the control. In addition to these data, N-terminal amino acid sequencing identified two proteins in NS0 CM as the protease inhibitors secretory leukocyte protease inhibitor and cystatin C.
Similar content being viewed by others
References
Abe, T.; Tominaga, Y.; Kikuchi, T.; Watanabe, A.; Satoh, K.; Watanabe, Y.; Nukiwa, T. Bacterial pneumonia causes augmented expression of the secretory leukoprotease inhibitor gene in the murine lung. Am. J. Respir. Crit. Care Med. 156:1235–1240; 1997.
Asami, O.; Nakamura, T.; Mura, T.; Ichihara, A. Identification of trypsin inhibitor in bovine pituitary extracts as a survival factor for adult rat hepatocytes in primary culture. J. Biochem. 95:299–309; 1984.
Catalioto, R. M.; Negrel, R.; Gaillard, D.; Ailhaud, G. Growth-promoting activity in serum-free medium of kallikreinlike arginylesteropeptidases from rat submaxillary gland. J. Cell Physiol. 130:352–360; 1987.
Cook, J. R.; Chen, J. K. Enhancement of transformed cell growth in agar by serine protease inhibitors. J. Cell. Physiol 136:188–193; 1988.
Davis, H.; Gascho, C.; Kiernan, J. A. Effects of aprotinin on organ cultures of the rat’s kidney. In Vitro 12:192–197; 1976.
Elliott, P.; Hohmann, A.; Spanos, J. Protease expression in the supernatant of Chinese Hamster Ovary cells grown in serum-free culture. Biotechnol. Lett. 25:1949–1952; 2003.
Ellis, K. J.; Morrison, J. F. Buffers of constant ionic strength for studying pH-dependent processes. Methods Enzymol. 87:405–426; 1982.
Fritz, H.; Wunderer, G. Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Arzneimittel-Forschung 33:479–494; 1983.
Ghetie, V.; Mihaescu, S. The hydrolysis of rabbit immunoglobulin G with purified cathepsins D and E. Immunochemistry 10:251–255; 1973.
Hargreaves, P. G.; Wang, F.; Anteliff, J.; Murphy, G.; Lawry, J.; Russell, R. G.; Croucher, P. I. Human myeloma cells shed the interleukin-6 receptor: inhibition by tissue inhibitor of metalloprotease-3 and a hydroxamate-based metalloprotease inhibitor. Br. J. Haematol. 101:694–702; 1998.
Henriksen, P. A.; Hitt, M.; Xing, Z. et al. Adenoviral gene delivery of elafin and secretory leukocyte protease inhibitor attenuates NF-kappa B-dependent inflammatory responses of human endothelial cells and macrophages to atherogenic stimuli. J. Immunol. 172:4535–4544; 2004.
Hewlett, G. Apropos aprotinin: a review. Biotechnology (NY) 8:565–566, 568; 1990.
Holen, I.; Drury, N. L.; Hargreaves, P. G.; Croucher, P. I. Evidence of a role for a non-matrix-type metalloprotease activity in the shedding of syndecan-1 from human myeloma cells. Br. J. Haematol. 114:414–421; 2001.
Hunt, L. T.; Barker, W. C.; Dayhoff, M. O. Epdermal growth factor: internal duplication and probable relation to pancreatic secretory trypsin inhibitor. Biochem. Biophys. Res. Commun. 60: 1020–8; 1974.
Ishidoh, K.; Kominami, E.; Gene regulation and extracellular functions of procathepsin L. Biol. Chem. 379:131–135; 1998.
Karl, D. W.; Donovan, M.; Flickinger, M. C. A novel acid protease released by hybridoma cells. Cytotechnology 3:157–169; 1990.
Kelly, T.; Borset, M.; Abe, E.; Gaddy-Kurten, D.; Sanderson, R. D. Matrix metalloproteases in multiple myeloma. Leuk. Lymphoma 37:273–281; 2000.
Kirschke, H.; Eerola, R.; Hopsu-Havu, V. K.; Bromme, D.; Vuorio, E. Antisense RNA inhibition of cathepsin L expression reduces tumorigenicity of malignant cells. Eur. J. Cancer 36:787–795; 2000.
Kratje, R. B.; Lind, W.; Wagner, R. Evaluation of the proteolytic potential of in vitro-cultivated hybridoma and recombinant mammalian cells. J. Biotechnol. 32:107–125; 1994.
Leber, T. M.; Balkwill, F. R. Zymography: a single-step staining method for quantitation of proteolytic activity on substrate gels. Anal. Biochem. 249:24–28; 1997.
Li, F.; An, H.; Seymour, T. A.; Bradford, S.; Morrissey, M. T.; Bailey, G. S.; Helmrich, A.; Barnes, D. W. Molecular cloning, sequence analysis and expression distribution of rainbow trout (Oncorhynchus mykiss) cystatin C. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 121B:135–143; 1998.
Nakamura, T.; Asami, O.; Tanaka, K.; Ichihara, A. Increased survival of rat hepatocytes in serum-free medium by inhibition of a trypsin-like protease associated with their plasma membranes. Exp. Cell Res. 155:81–91; 1984.
Neurath, H. Evolution of proteolytic enzymes. Science 224:350–357; 1984.
Pandiella, A.; Bosenberg, M. W.; Huang, E. J.; Besmer, P.; Massague, J. Cleavage of membrane-anchored growth factors involves distinct protease activities regulated through common mechanisms. J. Biol. Chem. 267:24028–24033; 1992.
Schlaeger, E. J.; Eggimann, B.; Gast, A. Proteolytic activity in the culture supernatants of mouse hybridoma cells. Dev. Biol. Stand. 66:403–408; 1987.
Solem, M.; Rawson, C.; Lindburg, K.; Barnes, D. Transforming growth factor beta regulates cystatin C in serum-free mouse embryo (SFME) cells. Biochem. Biophys. Res. Commun. 172:945–951; 1990.
Spens, E.; Häggström, L. Defined protein-free NS0 myeloma cell cultures: stimulation of proliferation by conditioned medium factors. Biotechnol. Prog. 21:87–95; 2005.
Tjin, E. P. M.; Derksen, P. W. B.; Kataoka, H.; Spaargaren, M.; Pals, S. T. Multiple myeloma cells catalyze hepatocyte growth factor (HGF) activation by secreting the serine protease HGF-activator. Blood 104:2172–2175; 2004.
Turk, B.; Turk, D.; Turk, V. Lysosomal cysteine proteases: more than scavengers. Biochim. Biophys. Acta 1477:98–111; 2000.
Van Erp, R.; Adorf, M.; Van Sommeren, A. P. G.; Gribnau, T. C. J. Monitoring of the production of monoclonal antibodies by hybridomas. Part II: characterization and purification of acid proteases present in cell culture supernatant. J. Biotechnol. 20:249–261; 1991.
Weber, E.; Gunther, D.; Laube, F.; Wiederanders, B.; Kirschke, H. Hybridoma cells producing antibodies to cathepsin L have greatly reduced potential for tumour growth. J. Cancer Res. Clin. Oncol. 120:564–567; 1994.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Spens, E., Häggström, L. Protease activity in protein-free NSO myeloma cell cultures. In Vitro Cell.Dev.Biol.-Animal 41, 330–336 (2005). https://doi.org/10.1007/s11626-005-0004-4
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11626-005-0004-4